menu search

Vertex pharmaceuticals stock: bear vs. bull

Vertex has climbed quite a bit this year -- and some potential good news may be priced in. Still, Vertex's late-stage programs offer it bright prospec...

July 3, 2023, 5:30 am

Strength seen in marinus pharmaceuticals (mrns): can its 5.4% jump turn into more strength?

Marinus pharmaceuticals (MRNS) witnessed a jump in share price last session on above-average trading vo...

July 3, 2023, 5:27 am

Astrazeneca sees £7bn wiped from its value as lung cancer results fall short of 'best-case scenario'

Shares in pharmaceutical giant AstraZeneca PLC (LSE:AZN) fell 4.4% in early trading, erasing £7.3bn fr...

July 3, 2023, 4:19 am

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of eton pharmaceuticals, inc. – eton

NEW YORK, July 02, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Eton ...

July 2, 2023, 5:07 am

Biomarin: fda approval of roctavian and massive voxzogo sales increase

BioMarin pharmaceutical Inc. received FDA approval for ROCTAVIAN for adults with severe Hemophilia A. N...

June 30, 2023, 6:08 pm

: madrigal pharmaceuticals’ stock up 5% as company starts rolling submission for fda approval of nash treatment

Madrigal pharmaceuticals Inc.’s stock MDGL rose 5% Friday after the company said it has started a rol...

June 30, 2023, 4:28 pm

Why aurinia pharmaceuticals stock is marching higher friday

Thursday, Aurinia's board of directors announced plans to explore strategic alternatives to bolster shareholder value. Investors are piling into the b...

June 30, 2023, 2:49 pm

Why is baudax bio (bxrx) stock up 130% today?

Against a broadly positive backdrop due to cooling inflation data, Baudax Bio (NASDAQ: BXRX ) nevertheless managed to resoundingly steal the spotlight...

June 30, 2023, 2:01 pm

For abbvie's blockbuster humira, cheaper competitors pose surprisingly little threat, analysts say

AbbVie's ABBV, +1.53% rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical produc...

June 30, 2023, 1:28 pm

Madrigal pharmaceuticals' stock up 5% as company starts rolling submission for fda approval of nash treatment

Madrigal pharmaceuticals Inc.'s stock MDGL, +5.00% rose 5% Friday after the company said it has started...

June 30, 2023, 12:28 pm

Reneo pharmaceuticals to participate in svb securities therapeutics forum

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Reneo pharmaceuticals, Inc. (NASDAQ: RPHM), a clinic...

June 30, 2023, 12:25 pm

Navidea biopharmaceuticals rejects prophase labs offer

Navidea Biopharmaceuticals Inc. NAVB, -2.38% announced Friday that it had rejected an unsolicited ProPh...

June 30, 2023, 9:44 am

Vertex to announce second quarter 2023 financial results on august 1

BOSTON--(BUSINESS WIRE)--Vertex pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quar...

June 30, 2023, 8:01 am

Nls pharmaceutics company update and webcast today postponed

NLS to Webcast its Event on Thursday, July 6, 2023, at 11:00 am ET ZURICH, SWITERLAND / ACCESSWIRE / June 30, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NL...

June 30, 2023, 8:00 am

Mgc pharma dismisses executive for share trading breaches

MGC pharmaceuticals said it had dismissed a senior executive following breaches of share trading rules....

June 30, 2023, 7:31 am

Spexis announces engagement with maxim group llc as m&a advisor to support evaluation of strategic transactions

Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, June 29, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage bio...

June 30, 2023, 5:15 am

Johnson & johnson: buy the market (technical analysis)

Johnson & Johnson is strategically shifting towards high-growth sectors like pharmaceuticals and medica...

June 29, 2023, 11:26 pm

Scpharmaceuticals: oversold territory, drug launch still looks robust

scpharmaceuticals' Furoscix dose-filling rates increased by 55% month over month in May. Despite the lo...

June 29, 2023, 11:05 pm

: fda approves biomarin’s gene therapy drug for hemophilia

BioMarin pharmaceutical Inc. BMRN received Food and Drug Administration approval of its gene therapy Ro...

June 29, 2023, 11:02 pm

Fda approves biomarin's gene therapy drug for hemophilia

BioMarin pharmaceutical Inc. BMRN, -3.57% received Food and Drug Administration approval of its gene th...

June 29, 2023, 7:02 pm


Search within

Pages Search Results: